India · Delayed Price · Currency is INR Zydus Wellness Statistics
Total Valuation
Zydus Wellness has a market cap or net worth of INR 160.93 billion. The enterprise value is 191.80 billion.
| Market Cap | 160.93B |
| Enterprise Value | 191.80B |
Important Dates
The last earnings date was Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | Jul 17, 2026 |
Share Statistics
Zydus Wellness has 318.16 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | 318.16M |
| Shares Outstanding | 318.16M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 22.58% |
| Float | 93.08M |
Valuation Ratios
The trailing PE ratio is 85.49 and the forward PE ratio is 38.12. Zydus Wellness's PEG ratio is 1.06.
| PE Ratio | 85.49 |
| Forward PE | 38.12 |
| PS Ratio | 3.55 |
| PB Ratio | 2.76 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 129.05 |
| P/OCF Ratio | 71.08 |
| PEG Ratio | 1.06 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.66, with an EV/FCF ratio of 153.81.
| EV / Earnings | 101.92 |
| EV / Sales | 4.23 |
| EV / EBITDA | 33.66 |
| EV / EBIT | 48.41 |
| EV / FCF | 153.81 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 5.62 |
| Debt / FCF | 25.68 |
| Interest Coverage | 3.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.38% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 3.58% |
| Revenue Per Employee | 26.93M |
| Profits Per Employee | 1.12M |
| Employee Count | 1,685 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Zydus Wellness has paid 591.00 million in taxes.
| Income Tax | 591.00M |
| Effective Tax Rate | 23.90% |
Stock Price Statistics
The stock price has increased by +33.09% in the last 52 weeks. The beta is -0.10, so Zydus Wellness's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | +33.09% |
| 50-Day Moving Average | 546.76 |
| 200-Day Moving Average | 473.26 |
| Relative Strength Index (RSI) | 38.48 |
| Average Volume (20 Days) | 31,119 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zydus Wellness had revenue of INR 45.37 billion and earned 1.88 billion in profits. Earnings per share was 5.92.
| Revenue | 45.37B |
| Gross Profit | 28.41B |
| Operating Income | 3.96B |
| Pretax Income | 2.47B |
| Net Income | 1.88B |
| EBITDA | 5.67B |
| EBIT | 3.96B |
| Earnings Per Share (EPS) | 5.92 |
Balance Sheet
The company has 1.15 billion in cash and 32.03 billion in debt, with a net cash position of -30.88 billion or -97.05 per share.
| Cash & Cash Equivalents | 1.15B |
| Total Debt | 32.03B |
| Net Cash | -30.88B |
| Net Cash Per Share | -97.05 |
| Equity (Book Value) | 58.26B |
| Book Value Per Share | 183.11 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 2.26 billion and capital expenditures -1.02 billion, giving a free cash flow of 1.25 billion.
| Operating Cash Flow | 2.26B |
| Capital Expenditures | -1.02B |
| Depreciation & Amortization | 1.71B |
| Net Borrowing | 28.23B |
| Free Cash Flow | 1.25B |
| FCF Per Share | 3.92 |
Margins
Gross margin is 62.63%, with operating and profit margins of 8.73% and 4.15%.
| Gross Margin | 62.63% |
| Operating Margin | 8.73% |
| Pretax Margin | 5.45% |
| Profit Margin | 4.15% |
| EBITDA Margin | 12.50% |
| EBIT Margin | 8.73% |
| FCF Margin | 3.15% |
Dividends & Yields
This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 0.23%.
| Dividend Per Share | 1.20 |
| Dividend Yield | 0.23% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.25% |
| Earnings Yield | 1.17% |
| FCF Yield | 0.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Zydus Wellness is 614.43, which is 21.48% higher than the current price. The consensus rating is "Buy".
| Price Target | 614.43 |
| Price Target Difference | 21.48% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 20.82% |
| EPS Growth Forecast (3Y) | 39.32% |
Stock Splits
The last stock split was on September 18, 2025. It was a forward split with a ratio of 5.
| Last Split Date | Sep 18, 2025 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |